首站-论文投稿智能助手
典型文献
Effect of ulinastatin on the inflammatory response after video-assisted thoracic lobectomy in patients with lung cancer: a randomized controlled study
文献摘要:
Background::The first-line treatment for lung cancer is surgical resection, and one-lung ventilation (OLV) is the most basic anesthetic management method in lung surgery. During OLV, inflammatory cytokines are released in response to the lung tissue damage and promote local and contralateral lung damage through the systemic circulation. We designed a randomized, prospective study to evaluate the effect of the urinary trypsin inhibitor (UTI) ulinastatin on the inflammatory response after video-assisted thoracic lobectomy in patients with lung cancer.Methods::Adult patients aged 19 to 70 years, who were scheduled for video-assisted thoracic lobectomy surgery to treat lung cancer between May 2020 and August 2020, were enrolled in this randomized, prospective study. UTI (300,000 units) mixed with 100 mL of normal saline in the ulinastatin group and 100 mL of normal saline in the control group was administered over 1 h after inducing anesthesia.Results::The baseline (T0) interferon-γ (IFN-γ)/interleukin-4 (IL-4) ratio was not different between the groups (6941.3 ± 2778.7 vs. 6954.3 ± 2752.4 pg/mL, respectively; P > 0.05). The IFN-γ/IL-4 ratio was significantly higher in ulinastatin group at 30 min after entering the recovery room than control group (20,148.2 ± 5054.3 vs. 6674.0 ± 2963.6, respectively; adjusted P < 0.017). Conclusion: Administering UTI attenuated the anti-inflammatory response, in terms of INF-γ expression and the IFN-γ/IL-4 ratio, after video-assisted thoracic surgery in lung cancer patients. Trial registration::Clinical Research Information Service of Korea National Institute of Health (CRIS), KCT0005533.
文献关键词:
Ulinastatin;Lung cancer;Video-assisted thoracic surgery;INF-γ;IL-4
作者姓名:
Hwang Won Jung;Joo Min A.;Joo Jin
作者机构:
Department of Anesthesiology and Pain Medicine, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea
引用格式:
[1]Hwang Won Jung;Joo Min A.;Joo Jin-.Effect of ulinastatin on the inflammatory response after video-assisted thoracic lobectomy in patients with lung cancer: a randomized controlled study)[J].中华医学杂志(英文版),2022(07):806-812
A类:
ulinastatin,Administering,KCT0005533,Ulinastatin
B类:
Effect,inflammatory,response,after,video,assisted,thoracic,lobectomy,patients,lung,cancer,randomized,controlled,study,Background,first,treatment,surgical,resection,one,ventilation,OLV,most,basic,anesthetic,management,method,surgery,During,cytokines,are,released,tissue,damage,promote,local,contralateral,through,systemic,circulation,We,designed,prospective,evaluate,effect,urinary,trypsin,inhibitor,UTI,Methods,Adult,aged,years,who,were,scheduled,between,May,August,enrolled,this,units,mixed,normal,saline,was,administered,inducing,anesthesia,Results,baseline,interferon,IFN,interleukin,not,different,groups,7 ,pg,respectively,significantly,higher,entering,recovery,room,than,adjusted,Conclusion,attenuated,anti,terms,INF,expression,Trial,registration,Clinical,Research,Information,Service,Korea,National,Institute,Health,CRIS,Lung,Video
AB值:
0.490162
相似文献
Application of regional citrate anticoagulation in patients at high risk of bleeding during intermittent hemodialysis:a prospective multicenter randomized controlled trial
Xiaoyan TANG;Dezheng CHEN;Ling ZHANG;Ping FU;Yanxia CHEN;Zhou XIAO;Xiangcheng XIAO;Weisheng PENG;Li CHENG;Yanmin ZHANG;Hongbo LI;Kehui LI;Bizhen GOU;Xin WU;Qian YU;Lijun JIAN;Zaizhi ZHU;Yu WEN;Cheng LIU;Hen XUE;Hongyu ZHANG;Xin HE;Bin YAN;Liping ZHONG;Bin HUANG;Mingying MAO-Division of Nephrology,Kidney Research Institute,West China Hospital of Sichuan University,Chengdu 610041,China;Department of Nephrology,People's Hospital of Jianyang City,Chengdu 641400,China;Department of Nephrology,the Second Affiliated Hospital of Nanchang University,Nanchang 330006,China;Department of Nephrology,Xiangya Hospital of Central South University,Changsha 410008,China;Department of Nephrology,Wuhan No.1 Hospital,Wuhan 430022,China;Department of Blood Purification,the First Affiliated Hospital of Guangxi Medical University,Nanning 530021,China;Department of Nephrology,Guiyang First People's Hospital,Guiyang 550002,China;Department of Nephrology,West China Hospital Sichuan University Jintang Hospital,Jintang 610400,China;Department of Nephrology,Meishan People's Hospital,Meishan 620020,China;Department of Nephrology,Ziyang People's Hospital,Ziyang 641300,China;Department of Nephrology,Ya'an People's Hospital,Ya'an 625000,China;Department of Nephrology,Chengdu Kangfu Kidney Disease Hospital,Chengdu 610047,China;Department of Nephrology,the First People's Hospital of Liangshan Yi Autonomous Prefecture,Xichang 615000,China
Post-discharge mortality in the first wave of COVID-19 in Turkey
Fusun Fakili;Pelin Duru Cetinkaya;Oya Baydar;Serap Argun Baris;Nurdan Kokturk;Seval Kul;Oguz Karcioglu;Pinar Aysert Yildiz;Ilim Irmak;Yonca Sekibag;Emel Azak;Sait Mulamahmutoglu;Caglar Cuhadaroglu;Bugra Kerget;Burcu Baran Ketencioglu;Hasan Selcuk Ozger;Gulcihan Ozkan;Zeynep Ture;Merve Ercelik;Tansu Ulukavak Ciftci;Ozlem Alici;Esra Nurlu Temel;Ozlem Ataoglu;Neslihan Kose;Muge Meltem Tor;Gulsah Gunluoglu;Sedat Altin;Onder Ozturk;Pinar Yildiz Gulhan;Ilknur Basyigit;Hasim Boyaci;I.Kivilcim Oguzulgen;Sermin Borekci;Bilun Gemicioglu;Ismail Hanta;Hacer Kuzu Okur;Gulseren Sagcan;Metin Akgun;Ali Fuat Kalyoncu;Oya Itil;Hasan Bayram-Department of Pulmonary Medicine,Faculty of Medicine,Gaziantep University,Gaziantep,Turkey;Department of Pulmonary Medicine,University of Health Sciences,Adana City Training and Research Hospital,Adana,Turkey;Department of Pulmonary Medicine,Faculty of Medicine,Cukurova University,Adana,Turkey;Department of Pulmonary Medicine,Faculty of Medicine,Kocaeli University,Kocaeli,Turkey;Department of Pulmonary Medicine,Faculty of Medicine,Gazi University,Ankara,Turkey;Department of Biostatistics,Faculty of Medicine,Gaziantep University,Gaziantep,Turkey;Department of Pulmonary Medicine,Halil Sivgin Cubuk State Hospital,Ankara,Turkey;Department of Infectious Disease,Faculty of Medicine,Gazi University,Ankara,Turkey;Department of Pulmonary Medicine,Faculty of Medicine,Hacettepe University,Ankara,Turkey;Department of Pulmonary Medicine,Cerrahpasa Faculty of Medicine,Istanbul University-Cerrahpasa,Istanbul,Turkey;Department of Infectious Disease and Clinical Microbiology,Faculty of Medicine,Kocaeli University,Kocaeli Turkey;Department of Pulmonary Medicine,Altunizade Acibadem Hospital,Istanbul,Turkey;Department of Pulmonary Medicine,Faculty of Medicine,Ataturk University,Erzurum,Turkey;Department of Pulmonary Medicine,Faculty of Medicine,Erciyes University,Kayseri,Turkey;Department of Pulmonary Medicine,Maslak Acibadem Hospital,Istanbul,Turkey;Department of Infectious Disease and Clinical Microbiology,Faculty of Medicine,Erciyes University,Kayseri,Turkey;Department of Pulmonary Medicine,Faculty of Medicine,Duzce University,Duzce,Turkey;Department of Infectious Disease,Faculty of Medicine,Turkiye Gazetesi Private Hospital,Istanbul,Turkey;Department of Infectious Diseases and Clinical Microbiology,Faculty of Medicine,Suleyman Demirel University,Isparta,Turkey;Department of Pulmonary Medicine,Bilecik Training and Research Hospital,Bilecik,Turkey;Department of Pulmonary Medicine,Faculty of Medicine,Zonguldak Bulent Ecevit University,Zonguldak,Turkey;Department of Pulmonary Medicine,University of Health Science,Yedikule Chest Diseases and Chest Surgery Training and Research Hospital,Istanbul,Turkey;Department of Pulmonary Medicine,Faculty of Medicine,Suleyman Demirel University,Isparta,Turkey;Department of Pulmonary Medicine,Faculty of Medicine,Dokuz Eylul University,Izmir,Turkey;Department of Pulmonary Medicine,Koc University Research Center for Translational Medicine(KUTTAM),Koc University School of Medicine,Istanbul,Turkey
Wenshen Jianpi recipe(温肾健脾方)induced immune reconstruction and redistribution of natural killer cell subsets in immunological non-responders of human immunodeficiency virus/acquired immune deficiency syndrome:a randomized controlled trial
TAO Zhuang;WANG Jian;CHEN Xin;LI Yonghong;YAN Yuguang;ZHANG Ao;ZOU Wen;LIU Ying-Research Center of AIDS Treatment with Traditional Chinese Medicine,China Academy of Chinese Medical Sciences,Beijing 100700,China;Institute of Basic Theory for Chinese Medicine,China Academy of Chinese Medical Sciences,Beijing 100700,China;Department of Integrated Traditional Chinese and Wetern Medicine,Kunming Hospital of Traditional Chinese Medicine,Kunming 650000,China;Department of Infection,No.6 People's Hospital of Shenyang City,Shenyang 110006,China;University of Chinese Academy of SoCIal SCIences,Beijing,100102,China
Safety and efficacy of Yupingfeng granules in children with recurrent respiratory tract infection: A randomized clinical trial
Xu Baoping;Li Xinmin;Hu Siyuan;Bao Yixiao;Chen Fengmei;Chen Zhimin;Du Yonggang;Liu Enmei;Liu Yufeng;Mou Qinghui;Su Baoling;Wang Bo;Xu Jianwen;Xu Guiping;Yang Qiaozhi;Gao Liwei;Liu Xiaohui;Li Lei;Ma Rong;Shen Kunling-China National Clinical Research Center of Respiratory Diseases, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, China;The First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China;Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China;Guangdong Women and Children Hospital and Health Institute, Guangzhou, Guangdong, China;Children’s Hospital of Zhejiang University School of Medicine, Zhejiang, China;Changzhi People’s Hospital, Changzhi, Shanxi, China;Children’s Hospital of Chongqing Medical University, Chongqing, China;The Fourth Affiliated Hospital of Liaoning University of Traditional Chinese Medicine, Shenyang, Liaoning, China;Qilu Children’s Hospital of Shandong University, Jinan, Shandong, China;Heji Hospital Affiliated to Changzhi Medical College, Changzhi, Shanxi, China;The Third Affiliated Hospital of Xinxiang Medical College, Xinxiang, Henan, China;Huizhou Traditional Chinese Medicine Hospital, Guangdong, China;Liaocheng People’s Hospital, Shandong, China;Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, China;Drug Research and Evaluation Technology Center, Chinese Association of Traditional Chinese Medicine, Beijing, China
Clinical outcomes of atezolizumab in combination with etoposide/platinum for treatment of extensive-stage small-cell lung cancer:A real-world,multicenter,retrospective,controlled study in China
Hanxiao Chen;Xiangjuan Ma;Jie Liu;Yu Yang;Yong Fang;Liping Wang;Jian Fang;Jun Zhao;Minglei Zhuo-Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing),Department Ⅰ of Thoracic Oncology,Peking University Cancer Hospital&Institute,Beijing 100142,China;Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing),Department Ⅱ of Thoracic Oncology,Peking University Cancer Hospital&Institute,Beijing 100142,China;Department of Pneumology,Shandong Cancer Hospital and Institute,Shandong First Medical University and Shandong Academy of Medical Sciences,Jinan 250117,China;Department of Oncology,the 2nd Affiliated Hospital of Harbin Medical University,Harbin 150001,China;Department of Oncology,Sir Run Run Shaw Hospital Zhejiang University School of Medicine,Hangzhou 310020,China;Department of Oncology,Baotou Cancer Hospital,Baotou 014030,China
Anlotinib as third-or further-line therapy for short-term relapsed small-cell lung cancer:subgroup analysis of a randomized phase 2 study(ALTER1202)
Jianhua Shi;Ying Cheng;Qiming Wang;Kai Li;Lin Wu;Baohui Han;Gongyan Chen;Jianxing He;Jie Wang;Haifeng Qin;Xiaoling Li-Department of Medical Oncology,Linyi Cancer Hospital,Linyi 276002,China;Department of Thoracic Medical Oncology,Jilin Cancer Hospital,Changchun 130012,China;Department of Internal Medicine,Affiliated Cancer Hospital of Zhengzhou University,Henan Cancer Hospital,Zhengzhou 450003,China;Department of Pulmonary Oncology,Tianjin Medical University Cancer Institute and Hospital,Tianjin 300060,China;Department of Thoracic Medical Oncology,The Affiliated Cancer Hospital of Xiangya School of Medicine,Central South University(Hunan Cancer Hospital),Changsha 410031,China;Department of Respiratory Medicine,Shanghai Chest Hospital,Shanghai Jiao Tong University,Shanghai 200030,China;Department of Respiratory Medicine,Harbin Medical University Cancer Hospital,Harbin 150081,China;Department of Thoracic Surgery,The First Affiliated Hospital of Guangzhou Medical University,Guangzhou 510120,China;National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,China;Department of Pulmonary Oncology,The Fifth Medical Centre of Chinese PLA General Hospital,Beijing 100039,China;Department of Medical Oncology,Liaoning Cancer Hospital,Shenyang 110042,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。